{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:50:58Z","timestamp":1791215458332,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012632","name":"Nazarbayev University","doi-asserted-by":"publisher","award":["111024CRP2013"],"award-info":[{"award-number":["111024CRP2013"]}],"id":[{"id":"10.13039\/501100012632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijid.2026.108871","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:07:45Z","timestamp":1781107665000},"page":"108871","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Prevalence of circulating hepatitis C virus genotypes and drug-resistant variants in former Soviet Union countries: A scoping review with genotype meta-analysis"],"prefix":"10.1016","volume":"170","author":[{"given":"Omega Mathew","family":"Immanuel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaoluwa Tolulope","family":"Fabiyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanar","family":"Issabekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuat P.","family":"Oshakbayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulzhan","family":"Abuova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya","family":"Konysbekova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreenu B.","family":"Vattipally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Bajpai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9497-0902","authenticated-orcid":false,"given":"Syed Hani","family":"Abidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ijid.2026.108871_bib0001","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3390\/v17081069","article-title":"Hepatitis C virus: epidemiological challenges and global strategies for elimination","volume":"17","author":"Toma","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2026.108871_bib0002","unstructured":"WHO. Hepatitis C. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c; 2025 [accessed 9 January 2026]."},{"key":"10.1016\/j.ijid.2026.108871_bib0003","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2014.1706","article-title":"Mutational diversity of NS5A and NS3 during triple therapy (telaprevir, pegylated-interferon-\u03b1 2b and ribavirin) for genotype 1b chronic hepatitis C: the Kobe Hepatitis Therapeutic Group","author":"Bai","year":"2014","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ijid.2026.108871_bib0004","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2024-001657","article-title":"Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries","author":"Mustafa","year":"2025","journal-title":"BMJ OPEN Gastroenterol"},{"key":"10.1016\/j.ijid.2026.108871_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9701920","article-title":"Transmission of HIV and HCV within former Soviet Union countries","volume":"2020","author":"Aibekova","year":"2020","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.ijid.2026.108871_bib0006","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ijid.2020.12.068","article-title":"Prevalence of HIV, HCV and HBV in Central Asia and the Caucasus: a systematic review","volume":"104","author":"Davlidova","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.ijid.2026.108871_bib0007","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3390\/v17020163","article-title":"A comprehensive review of antiviral therapy for Hepatitis C: the long journey from interferon to pan-genotypic direct-acting antivirals (DAAs)","volume":"17","author":"Di Marco","year":"2025","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijid.2026.108871_bib0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/v13010041","article-title":"Therapy implications of Hepatitis C virus genetic diversity","volume":"13","author":"Martinez","year":"2020","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijid.2026.108871_bib0009","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.ijid.2026.108871_bib0010","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.jhep.2018.07.023","article-title":"No impact of resistance-associated substitutions on the efficacy of sofosbuvir, velpatasvir, and voxilaprevir for 12 weeks in HCV DAA-experienced patients","volume":"69","author":"Sarrazin","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijid.2026.108871_bib0011","unstructured":"CDA Foundation. Polaris global distribution\u2014CDA foundation. https:\/\/cdafound.org\/polaris\/global-distribution\/; 2025 [accessed 23 January 2026]."},{"issue":"1","key":"10.1016\/j.ijid.2026.108871_bib0012","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s41124-017-0026-z","article-title":"Hepatitis C in Eastern Europe and Central Asia: a survey of epidemiology, treatment access and civil society activity in eleven countries","volume":"2","author":"Maistat","year":"2017","journal-title":"Hepatol Med Policy"},{"issue":"7","key":"10.1016\/j.ijid.2026.108871_bib0013","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2026.108871_bib0014","series-title":"JBI manual for evidence synthesis","article-title":"Systematic reviews of aetiology and risk","author":"Moola","year":"2024"},{"issue":"11","key":"10.1016\/j.ijid.2026.108871_bib0015","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J Epidemiol Community Health"},{"issue":"7","key":"10.1016\/j.ijid.2026.108871_bib0016","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ijid.2026.108871_bib0017","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis","volume":"16","author":"Furuya-Kanamori","year":"2018","journal-title":"Int J Evid Based Healthc"},{"issue":"1","key":"10.1016\/j.ijid.2026.108871_bib0018","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1542\/peds.100.1.109","article-title":"Summary of major changes in the 1997 Red Book: report of the Committee on Infections Diseases","volume":"100","author":"Peter","year":"1997","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.ijid.2026.108871_bib0019","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/jrsm.1547","article-title":"Meta-analysis of prevalence: I2 statistic and how to deal with heterogeneity","volume":"13","author":"Migliavaca","year":"2022","journal-title":"Res Synth Methods"},{"issue":"1","key":"10.1016\/j.ijid.2026.108871_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12874-018-0611-x","article-title":"Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach","volume":"18","author":"Munn","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijid.2026.108871_bib0021","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-11-517","article-title":"Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia","volume":"11","author":"Uusk\u00fcla","year":"2011","journal-title":"BMC PUBLIC Health"},{"key":"10.1016\/j.ijid.2026.108871_bib0022","doi-asserted-by":"crossref","DOI":"10.1186\/s13027-016-0099-0","article-title":"Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe","volume":"11","author":"Petruzziello","year":"2016","journal-title":"Infect Agent Cancer."},{"issue":"10","key":"10.1016\/j.ijid.2026.108871_bib0023","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/pathogens13100841","article-title":"Hepatitis C virus infection in Europe","volume":"13","author":"Sim\u00e3o","year":"2024","journal-title":"Pathogens"},{"issue":"4","key":"10.1016\/j.ijid.2026.108871_bib0024","doi-asserted-by":"crossref","first-page":"790","DOI":"10.3390\/v14040790","article-title":"Elimination of HCV in Russia: barriers and perspective","volume":"14","author":"Isakov","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijid.2026.108871_bib0025","article-title":"Significance of mutations in the region coding for NS3\/4 protease in patients infected with HCV genotype 1b","author":"Flisiak","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.ijid.2026.108871_bib0026","doi-asserted-by":"crossref","DOI":"10.1097\/HEP.0000000000000379","article-title":"Virological characterization of treatment failures and retreatment outcomes in patients infected with unusual HCV genotype 1 subtypes","author":"Vo-Quang","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ijid.2026.108871_bib0027","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1879366521998808","article-title":"From \u201cGreater Europe\u201d to \u201cGreater Eurasia\u201d: status concerns and the evolution of Russia\u2019s approach to alignment and regional integration","volume":"12","author":"Krickovic","year":"2021","journal-title":"J Eurasian Stud"},{"issue":"2","key":"10.1016\/j.ijid.2026.108871_bib0028","doi-asserted-by":"crossref","first-page":"vez041","DOI":"10.1093\/ve\/vez041","article-title":"Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k\/1b lineage","volume":"5","author":"Hostager","year":"2019","journal-title":"Virus Evol"},{"issue":"9","key":"10.1016\/j.ijid.2026.108871_bib0029","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/ijms17091384","article-title":"Heads or tails: genotyping of Hepatitis C virus concerning the 2k\/1b circulating recombinant form","volume":"17","author":"Schuermans","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.ijid.2026.108871_bib0030","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.3390\/ijerph22111670","article-title":"A bibliometric analysis of the HCV drug-resistant majority and minority variants","volume":"22","author":"Immanuel","year":"2025","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.ijid.2026.108871_bib0031","doi-asserted-by":"crossref","DOI":"10.1186\/s12985-020-01381-3","article-title":"Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols","author":"Caputo","year":"2020","journal-title":"Virol J"},{"key":"10.1016\/j.ijid.2026.108871_bib0032","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-25649-6","article-title":"Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure","author":"Smith","year":"2021","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.ijid.2026.108871_bib0033","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.3390\/v14112570","article-title":"Recent information on pan-genotypic direct-acting antiviral agents for HCV in chronic kidney disease","volume":"14","author":"Fabrizi","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.ijid.2026.108871_bib0034","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","author":"Blach","year":"2022","journal-title":"LANCET Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.ijid.2026.108871_bib0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058757","article-title":"Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study","volume":"12","author":"Tasavon Gholamhoseini","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2026.108871_bib0036","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drugpo.2018.06.011","article-title":"Risk behaviours and viral infections among drug injecting migrants from the former Soviet Union in Germany: results from the DRUCK-study","volume":"59","author":"Derks","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.ijid.2026.108871_bib0037","unstructured":"WHO. Hepatitis. 2024 [accessed 29 May 2026]. https:\/\/www.who.int\/multi-media\/details\/elimination-of-hepatitis-by-2030."},{"issue":"13","key":"10.1016\/j.ijid.2026.108871_bib0038","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3390\/healthcare11131946","article-title":"Antimicrobial resistance: a growing serious threat for global public health","volume":"11","author":"Salam","year":"2023","journal-title":"Healthcare"},{"key":"10.1016\/j.ijid.2026.108871_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2026.108526","article-title":"Transmission of high-level drug-resistance mutations in HIV-1 subtype A6 circulating among former Soviet Union countries","volume":"167","author":"Bakuova","year":"2026","journal-title":"Int J Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226005060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:52:43Z","timestamp":1791211963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226005060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":39,"alternative-id":["S1201971226005060"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108871","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of circulating hepatitis C virus genotypes and drug-resistant variants in former Soviet Union countries: A scoping review with genotype meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108871","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108871"}}